Saturday, July 11, 2026

biotech · Obesity

Timmune Biotech

Timmune Biotech clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
0
Patents
0
Intelligence · Clinical Programs

Timmune Biotech projects

1 ClinicalTrials.gov programs sponsored by Timmune Biotech.

Timmune Biotech has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. ALT-801

    Timmune Biotech

    Obesity

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Timmune Biotech have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.